Tumor Immunology Section
Surgery Oncology Branch
Mission
The Tumor Immunology Section of the Surgery Branch is dedicated to developing and conducting new cancer treatments based on stimulation of the immune system of the cancer patient. Current clinical trials are available for patients with melanoma and cancers of the breast, colon, lung, pancreas, ovary, kidney, and others.
Investigator
Steven Rosenberg, M.D., Ph.D.
Head, Tumor Immunology Section
Branch Chief
Surgery Oncology Branch, CCR, NCI
Dr. Steven A. Rosenberg is Chief of Surgery at the National Cancer Institute in Bethesda, Md., and a Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences in Washington, D.C.
Dr. Rosenberg received his B.A. and M.D. degrees from The Johns Hopkins University in Baltimore, Md., and his Ph.D. in Biophysics from Harvard University. After completing his residency training in surgery in 1974 at the Peter Bent Brigham Hospital in Boston, Mass., Dr. Rosenberg became Chief of Surgery at the National Cancer Institute, a position he has held to the present time.
Read more
Back to Top
